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Chapter 1. Background and purpose 
1.1 Inflammatory response of innate immune system 
Introduction of inflammation 
The redness, swelling, fever, pain and loss of function are triggered by inflammation. 
The increasing recruitment of leukocytes and production of pro-inflammatory mediators 
and cytokines contribute to the redness, swelling, fever, pain and dysfunction of 
inflammation. The inflammatory response is initiated by harmful conditions and stimuli 
such as microbial infection, tissue damage and dysfunction. Inflammation is a pivotal 
contributor in process of host defense and tissue repair [1]. The inflammatory response 
of innate immune cells is the primary response to microorganism infection and 
damaging cells. The dendritic cells (DCs) and macrophages not only produce 
pro-inflammatory mediators and cytokines against microbial pathogens, but also 
provide antigen presentation to initiate adaptive immune system [2]. Inflammatory 
response of innate immune cells is triggered by germline-encoded pattern recognition 
receptors (PRRs) which recognize molecules of pathogens and damaged cells. The 
pathogen-associated molecular patterns (PAMPs) are regarded to be pathogen-specific 
molecules including bacteria lipopolysaccharides (LPS), flagellins, fungal glucans, 
CpG-DNA and viral DNA/RNA. The damage-associated molecular patterns (DAMPs) 
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are considered to be molecular components representing endogenous alarms. DAMPs 
are released forms of damaged cells such as advanced glycation end products (AGEs) 
and mitochondrial and nuclear DNA. A part of DAMPs are considered to be danger 
signals which induce inflammatory responses including heat-shock proteins (HSPs), 
high mobility group box 1 (HMGB1), fibrinogen and S100 proteins [3, 4]. Toll-like 
receptors (TLRs), nucleotide-binding and oligomerization domain (NOD)-like receptors 
(NLRs), C-type lectin receptors (CLRs), receptor for advanced glycation end products 
(RAGE) and retinoic acid-inducible gene (RIG)-I-like receptors (RLRs) are PRRs 
which play important roles in elimination of microbial pathogens infection and 
damaging cells [5, 6]. 
 
The pattern recognition receptors 
The TLRs are central PRRs in host cell recognition and response to several microbial 
pathogens such as bacteria, mycobacteria, viruses, parasites and fungi. Toll/interleukin-1 
receptor (TIR) and leucine-rich repeat (LRR) are central components of TLR. TIR is 
cytosolic domain to transduce signaling pathways, and LRR is extracellular domain to 
recognize pathogens [7]. TLRs, including transmembrane receptor TLR1, TLR2, TLR4, 
TLR5, TLR6, cytoplasmic receptor TLR3, TLR7, TLR8, and TLR9, broadly recognize 
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PAMPs and DAMPs. The ligands of transmembrane receptor TLR1 are lipopeptides, 
TLR2 (lipopeptides/lipoprotein), TLR4 (LPS, HSPs, fibrinogen and HMGB1), TLR5 
(flagellins), and TLR6 (lipopeptides), whereas cytoplasmic receptor TLR3 recognizes 
double-stranded RNA, TLR7 (single-stranded RNA), TLR8 (singe-stranded RNA) and 
TLR9 (CpG-DNA) [8, 9]. At present, the ligand of TLR10 remains unclear. 
 
The NLRs are cytoplasmic receptors that recognize PAMPs (bacterial peptidoglycans, 
viral RNA and microbial toxins) and DAMPs (adenosine triphosphate (ATP) and 
monosodium urate (MSU) crystals). NLRs include four subfamilies NLRA/Class II 
transactivator (CIITA), NLRB/neuronal apoptosis inhibitor proteins (NAIPs), NLRC, 
and NLRP [10]. In addition, NLRs comprise a C-terminal series of LRR and an 
N-terminal homotypic protein-protein interaction domain. The interaction domain of 
NLRAs is acid transactivation domain. NLRBs contain baculovirus inhibitor of 
apoptosis protein repeat (BIR). NLRCs contain a caspase-recruitment domain (CARD), 
and pyrin domain (PYD) [11]. The NOD1 and NOD2 trigger inflammatory response by 
recognizing Gram-negative and Gram-positive bacterial peptidoglycan. NLRPs are key 
regulators of inflammasomes which are a group of protein complexes and produce 
pro-inflammatory cytokine interleukin-1β (IL-1β) and IL-18 [12]. Especially, NLRP3 
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inflammasome is a regulator in pathogenesis of diabetes, atherosclerosis and several 
immune-mediated diseases [12]. The NLRP3 inflammasome complex is composed of 
NLRP3, apoptosis-associated speck-like protein containing a caspase-activation and 
-recruitment domain (ASC) and caspase-1. The activation of NLRP3 inflammasome in 
macrophages is triggered by two steps (priming and activation). TLRs or tumor necrosis 
factor-α (TNF-α) receptor-mediated nuclear factor-𝜅B (NF-κB) produces NLRP3, 
pro-IL-1β and pro-IL-18 in the priming steps, and then PAMPs or DAMPs activate 
NLRP3, and increase ASC oligomerization in the activation step. Subsequently, ASC 
converts caspase-1 into the active form, and activated caspase-1 cleaves the pro-IL-1β 
and pro-IL-18 [13]. 
 
The CLRs such as Dectin-1, Dectin-2, mannose receptor (MR), Dendritic cell-specific 
intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) and 
macrophage-inducible C-type lectin (Mincle) recognize fungal, viral and bacterial 
carbohydrates, and initiate to antifungal immune response directly [14]. Dectin-1 
recognizes β-glucan (a component of fungal cell wall) and transduces the spleen 
tyrosine kinase (Syk) signaling. Dectin-2 and MR contribute to recognition of high 
mannose-type carbohydrates. DC-SIGN binds high mannose and fucose to recognize 
7 
 
fungi and virus. In particular, Mincle not only binds glycolipids and α-mannose, but also 
recognizes spliceosome-associated protein 130 (SAP130) which is ribonucleoprotein of 
death cells [15]. 
 
The RLRs are the cytoplasmic receptors that recognize RIG-I, melanoma 
differentiation-associated gene 5 (MDA5) and laboratory of genetics and physiology 
gene 2 (LGP2). RIG-I and MDA5 are activated by viral double-stranded RNA. 
Activated RIG-I and MDA5 bind with RLRs, and transduce the essential adaptor 
protein mitochondrial antiviral signaling (MAVS) to initiate antiviral immune response. 
In contrast, LGP2 negatively regulates RIG-I and MDA5 [16]. Thus, the RLRs are 
crucial contributors to recognize RNA virus and exert antiviral effects. 
 
The RAGE is a transmembrane receptor of DAMPs such as AGEs, S100 proteins, 
phosphatidylserine and advanced oxidation protein products (AOPPs) and HMGB1. 
Interestingly, RAGE also recognizes LPS and triggers inflammatory response [6]. 
RAGE regulates inflammation and cell migration by recognition of different ligands. 
The engagement of HMGB1 stimulates monocyte migration, and binding with S100 
proteins induces synthesis of pro-inflammatory cytokines [4]. 
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Taken together, the TLRs are presented on several immune cells (DCs, macrophages, B 
cells and T cells), fibroblasts and epithelial cells, and wildly recognize various microbial 
pathogens and endogenous molecules [3]. TLRs are central contributors to recognition 
of PAMPs and DAMPs. It is considered that TLRs initiate several signaling transduction 
pathways to trigger inflammation [7]. 
 
TLR4 signaling transduction pathways 
Among several TLRs, TLR4 is a crucial receptor for recognition of bacterial LPS and 
leading to inflammatory response. Myeloid differentiation 2 (MD2) assists TLR4 to 
recognize LPS, and CD14 and LPS-binding protein (LBP) enhance LPS binding to 
TLR4/MD2 receptor complex. Subsequently, TIR-like domains are recruited, and 
transduce signal to other adaptor proteins. The downstream adaptor proteins include 
myeloid differentiation primary response protein 88 (MyD88), MyD88 adaptor-like 
(Mal) as known as TIR domain containing adaptor protein (TIRAP), TIR 
domain-containing adaptor inducing interferon-β (TRIF, also known as TIR-containing 
adapter molecule-1 (TICAM-1)), TRIF related adaptor molecule (TRAM, also called 
TICAM-2) and sterile-α and armadillo motif containing protein (SARM) [17]. 
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MyD88-dependent pathway and TRIF-dependent pathway (MyD88-independent 
pathway) have been defined in TLR4 signaling transduction pathways. The 
MyD88-dependent pathway regulates the early stage of acute inflammation. In contrast, 
the TRIF-dependent pathway contributes to the late stage of acute inflammation [18]. In 
the MyD88-dependent pathway, the recruitment of MyD88 activates IL-1 
receptor-associated kinases 1 (IRAK1), IRAK2, IRAK4 and TNF receptor-associated 
factor 6 (TRAF6). Subsequently, transforming growth factor β-activated kinase 1 
(TAK1)-binding protein 2 (TAB2) and TAK1-binding protein 3 (TAB3) are transduced, 
and then TAB2 and TAB3 activate TAK1. TAK1 is a mitogen-activated protein kinase 
kinase kinase (MAPKKK) that regulates activity of MAPKs. The MAPKs including 
c-JUN N-terminal kinase (JNK), p38 MAPK and extracellular signal-regulated kinases 
(ERK) crucially regulate downstream transcription factors such as activator protein-1 
(AP-1) and NF-𝜅B [8]. These transcription factors regulate production of 
pro-inflammatory mediators and cytokines. Moreover, the Mal (TRIF) regulates 
activation of NF-𝜅B through the bridging of MyD88-dependent pathway. 
 
On the other hand, the TRIF-dependent pathway is initiated by recruitment of TRIF and 
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TRAM, and activates TRAF3, tank-binding kinase 1 (TBK1) and inhibitor-κB kinase 𝜀 
(IKK𝜀). These signaling transduction factors induce nuclear translocation of interferon 
regulatory factor-3 (IRF-3) and IRF-7. Subsequently, interferon inducible protein-10 
(IP-10), type I interferon (IFN) and regulated on activation, normal T cell expressed and 
secreted (RANTES) are produced [9]. TRIF and TRAM also regulate activation of 
NF-𝜅B without MyD88 [19]. Furthermore, the SARM downregulates IRF-3, IRF-7 and 
NF-𝜅B by TRAM [18]. 
 
Taken together, the LPS-induced TLR4 signaling is regulated by these five adaptor 
proteins (MyD88, Mal, TRIF, TRAM and SARM), and activated transcription factor 
AP-1, NF-𝜅B, IRF-3 and IRF-7 to produce pro-inflammatory mediators and cytokines. 
The MyD88-dependent pathway is a pivotal regulator of inflammatory host response to 
LPS. Thus, MyD88-dependent pathway signaling transduction factors are critical 
contributors for acute inflammation such as MAPK and NF-𝜅B. 
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Fig. 1. The TLR4 signaling transduction pathways. 
 
LPS-induced pro-inflammatory mediators and cytokines 
The LPS-induced TLR4 signaling transduction factors lead to produce several 
pro-inflammatory mediators and cytokines by LPS-activated macrophages. The major 
pro-inflammatory mediators including nitric oxide (NO) and prostaglandin E2 (PGE2) 
cause redness, swelling, fever and pain. Inducible NO synthase (iNOS, also called 
NOS2) synthesizes NO from L-arginine. The production of iNOS is regulated by NF-𝜅B 
after immunological stimulation [20]. NO is transformed to cytotoxic free radical 
peroxynitrite (ONOO-) by superoxide (O2-), and kills microorganism by free radical 
reaction. The overproduction of NO contributes cell death (necrosis and apoptosis) and 
12 
 
tissue destruction by cytotoxicity and oxidative stress [21]. Additionally, iNOS is a 
harmful enzyme involved in development of inflammatory diseases [22]. 
 
Another major pro-inflammatory mediator, PGE2 is a lipid pro-inflammatory mediator. 
The cell membrane phospholipid and phospholipase A2 (PLA2) release arachidonic acid 
(AA), and cyclooxygenase-2 (COX-2) converts AA to PGH2 through cyclooxygenase 
and peroxidase activity. Subsequently, PGH2 is transformed to PGE2 by PGE synthase 
[23]. The PGE2 contributes to vascular hyperpermeability, immune cell infiltration and 
plasma leakage in acute inflammation. Therefore, COX-2 inhibitors suppress prostanoid 
biosynthesis, and decrease vasodilatation, vascular permeability and recruitment of 
immune cells in inflammation [23]. On the other hand, NO causes vascular dysfunction 
characterized by vascular hyperpermeability due to endothelial cell death [21]. 
Interestingly, it has been reported that there is a cross-talk between iNOS and COX-2. 
NO elicits prostaglandin synthesis via upregulation of COX-2 activity. In contrast, 
COX-2 inhibitor does not affect iNOS expression [24]. 
 
TNF-α, IL-1β and IL-6 are crucial pro-inflammatory cytokines produced by 
LPS-activated macrophages and lymphocytes. IL-1β and TNF-α contribute to activate 
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immune cells, and induce fever and coagulation in inflammation. Particularly, TNF-α is 
a master regulator of pro-inflammatory cytokine production. Both IL-1β and TNF-α 
augment inflammatory cascades, and induce severe inflammatory reaction in an 
autocrine and paracrine manner by activated macrophages. IL-6 activates B and T 
lymphocytes, and also contributes fever [25]. Additionally, IL-6 and IL-12 are family 
cytokines that share subunit and receptor by structural relation. IL-12 is a critical 
contributor to connect innate immune system to adaptive immune system [26]. 
Especially, IL-12p40 shares the p40 subunit with IL-23, and induces inflammation 
together with IL-17 [27]. 
 
1.2 LPS-induced systemic inflammation (sepsis and exercise-induced endotoxemia) 
Introduction of endotoxemia 
The high level of LPS (endotoxin) in blood leads to systemic inflammation such as 
endotoxemia and sepsis. The endotoxemia is characterized that immoderate LPS into 
the bloodstream, which triggers production of pro-inflammatory mediators and 
cytokines by activation and recruitment of leukocytes and macrophages. Subsequently, 
augmentation of these immune responses causes harmful systemic inflammation that 
attributed systemic inflammatory response syndrome (SIRS). The SIRS is defined by 
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two or more clinical finding (1. body temperature <36°C or >38°C, 2. heart rate >90 
beats/min, 3. respiratory rate >20 times/min or PaCO2 <32 mmHg and 4. white blood 
cell (WBC) count >12000 cells/μL or <4000 cells/μL, or >10% immature (band) forms) 
[25]. 
 
The pathogenesis of sepsis 
The infection of gram-negative bacteria and other pathogens contributes to pathogenesis 
of sepsis. The gram-negative bacterial LPS and other microbial component initiate 
harmful systemic host response. The overproduction of pro-inflammatory mediators and 
cytokines by activated innate immune cells lead to cell apoptosis and necrosis. The 
inflammatory cascades contribute to multiple organ damage, sepsis and septic shock 
[28]. TLR4/MD2 receptor complex is central contributor to initiate systemic 
inflammation of endotoxemia, and transduce signaling to produce pro-inflammatory 
mediators and cytokines. The hypercytokinemia (known as cytokine storm) is 
overspilling cytokines in blood. TNF-α, IL-1β, IL-6, IL-12 and IL-17 have been found 
that are elevated in sepsis. These pro-inflammatory cytokines are considered that are 
main cytokines in pathogenesis of sepsis [29]. On the other hand, HMGB1 as a 
pro-inflammatory mediator contributes to late stage of sepsis [30]. Especially, HMGB1 
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also binds to TLR4, and initiates TLR4-mediated inflammatory response. The 
hypercytokinemia causes endothelial cell necrosis and dysfunction, and then leads to the 
vascular hyperpermeability and plasma leakage. Concurrently, pyrogenic cytokine IL-1β 
and TNF-α contribute to fever and coagulation, and IL-6 also contributes to fever. In 
addition, these pro-inflammatory cytokines induce production of PGE2 and NO. The 
hypercytokinemia contributes to fever, vasodilation, coagulopathy and capillary leak. 
Taken together, the hypercytokinemia causes to multiple organ damage, sepsis, and 
septic shock [28]. 
 
The exercise-induced endotoxemia and systemic inflammation 
The endotoxemia is not only triggered by pathogenic bacterial infection, but also 
initiated by intestinal gram-negative bacterial translocation. The hyperpermeability of 
intestine increases translocation of intestinal gram-negative bacteria. It has been found 
that prolonged and strenuous exercise causes the hyperpermeability of intestine. It 
increases the blood supply of muscle and cardiopulmonary system, but reduces the 
blood supply of gastrointestinal (GI) system by the prolonged and strenuous 
exercise-induced redistribution of blood flow. It leads to gastrointestinal ischemia 
during exercise, and the perfusion of gastrointestinal evolves inflammation after 
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exercise [31]. The exercise-induced redistribution of blood flow contributes to 
hyperpermeability of intestine through intestinal barrier dysfunction and gastrointestinal 
ischemia [31]. Concurrently, the prolonged and strenuous exercise increases core body 
temperature that leads to hyperthermia, and exercise-induced hyperthermia also 
augments intestinal hyperpermeability [32]. The intestinal gram-negative bacteria 
translocate into blood, and increase circulatory bacterial LPS. It leads to endotoxemia 
during prolonged and strenuous exercise. 
 
On the other hand, exercise-induced endotoxemia triggers production PGE2, TNF-α, 
IL-1β and IL-6 by activated macrophages. These pro-inflammatory mediator and 
cytokines contribute to fever by pyrogenic response, and even result in exertional heat 
stroke. The pathogenesis of heat stroke is not only associated with hyperthermia, but 
also involved in endotoxemia [33]. Lim and Suzuki suggested that the pathogenesis of 
heat stroke is explained by dual-pathway model (DPM) of hyperthermia and 
endotoxemia [34]. 
 
Non-steroidal anti-inflammatory drugs (NSAIDs) reduces core body temperature 
through inhibitory effect of COX-2, but a part of NSAIDs (aspirin and ibuprofen) 
17 
 
enhance permeability of intestine [35]. Although the probiotic supplementation 
decreases exercise-induced intestinal barrier dysfunction, it does not affect 
exercise-induced pro-inflammatory cytokine production [36, 37]. On the other hand, the 
ascorbic acid supplementation suppresses exercise-induced endotoxemia [38], and also 
reduces sepsis-induced organ damage [39]. Many polyphenols which derived from 
herbs, fruits, and vegetables exhibit anti-inflammatory effects, and attenuate 
LPS-induced inflammation [40, 41]. 
 
1.3 The anti-inflammatory effects of Camellia sinensis (L.) O. Kuntze 
The introduction of Camellia sinensis (L.) O. Kuntze 
Tea is produced from the leaves of Camellia sinensis (L.) O. Kuntze, and exhibits 
various health benefits. Tea has been found that contains abundant polyphenols, and has 
potential beneficial effects such as reduction of cardiovascular diseases risk [42], 
anti-obesity [43], inhibition of tumorigenesis [44] and improvement of type II diabetes 
[45]. The three major categories of tea, green tea, oolong tea and black tea are all 
produced from the Camellia sinensis, but are produced with different process of 
fermentation. The green tea is produced without fermentation, oolong tea is fermented 
partially, and black tea is fermented fully. The variety of polyphenols of tea is associated 
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with process of fermentation. The green tea contains the most amount of 
(-)-epigallocatechin 3-gallate (EGCG) and total catechin (flavan-3-ols) [46]. After 
enzymatic fermentation process, the amount of EGCG and total catechin of black tea 
become lower than green tea, and polyphenol oxidase converts into theaflavins and 
thearubigins [44]. Since green tea is produced without fermentation, the bioactivity 
compounds which are isolated from green tea are the nearest the bioactivity compounds 
which are isolated from leaves of Camellia sinensis among black tea, oolong tea and 
others. 
 
The major bioactivity compounds of green tea (Camellia sinensis) 
The major bioactivity compounds of green tea are flavonoids include (+)-catechin (C), 
(-)-epicatechin (EC), (+) gallocatechin (GC), (-)-epigallocatechin (EGC), 
(+)-gallocatechin gallate (GCG), (-)-epicatechin gallate (ECG) and EGCG. The EGCG 
(48~55%) is the most abundant component derived from green tea, and other 
compounds are ECG (9~12%), EGC (9~12%) and EC (5~7%) [47]. According to the 
chemical structure of polyphenols, catechin contain a C-ring which is a dihydropyran 
heterocycle with a hydroxyl group on carbon 3, and C-ring connects two or more 
aromatic rings (A- and B-rings) which bears one or more aromatic hydroxyl. This 
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chemical structure is called flavan-3-ol. Moreover, GCG, ECG and EGCG are with a 
gallate D-ring. The B-ring has been defined two moiety types which are catechol B-ring 
and pyrogallol B-ring. C, EC, GC and EGC contain catechol B-ring. In contrast, GCG 
and EGCG contain pyrogallol B-ring (Fig. 2). The chemical structure A-ring is near a 
resorcinol moiety [47]. 
Fig. 2. The chemical structure of polyphenols in green tea (Camellia sinensis). 
Reference： https://www.sigmaaldrich.com 
 
The several epidemiological evidences have indicated that green tea consumption might 
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reduce inflammation and prevent lifestyle-related diseases such as cardiovascular 
diseases and cancers [44, 48]. The green tea polyphenols suppress the production of 
pro-inflammatory mediator NO and cytokines [49]. Notably, EGCG has been 
demonstrated that exerts anti-inflammatory properties on LPS-induced inflammation in 
vitro and in vivo [50, 51]. These polyphenols derived from green tea (Camellia sinensis) 
have been considered that contribute to the anti-inflammatory effects of Camellia 
sinensis, and might be potential compounds for treating LPS-induced inflammation. 
 
1.4 The anti-inflammatory effects of Psoralea corylifolia L. (Fabaceae) 
The introduction of Psoralea corylifolia L. (Fabaceae) 
An annual herb, Psoralea corylifolia L. (Fabaceae) is a medicinal plant which has been 
used in Ayurvedic medicine and traditional Chinese medicine, as well as applied in 
traditional herbal medicine in other Asian countries. Psoralea corylifolia L. has been 
used as a traditional medicine treatment for a variety of diseases and symptoms such as 
cardiovascular diseases, osteoporosis, psoriasis, leukoderma, and inflammatory skin 
diseases [52]. It is also a tonic food in Asian countries. The whole plant of Psoralea 
corylifolia L., especially the seed or fruit, has significant medicinal value in traditional 
medicine. The dried fruit of Psoralea corylifolia L. is called Buguchi or Buguzhi in 
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Chinese. In the previous studies, the extract of Psoralea corylifolia L. suppresses the 
pro-inflammatory gene expression in live by high-fat diet-induced obese mice [53], and 
exerts antitumor properties and immunomodulatory effects [54]. 
 
The flavonoids of Psoralea corylifolia L. 
The major active constituents of Psoralea corylifolia L. are polyphenolic compounds 
including coumarins, flavonoids, and meroterpenes [55]. In the previous studies, the 
flavonoids of Psoralea corylifolia L exert anti-inflammatory effects. Bavachin 
attenuates chemokine production and cell migration by IL-1β-stimulated THP-1 
monocytic cells [56]. Neobavaisoflavone decreases production of pro-inflammatory 
cytokines by LPS plus IFN-γ-stimulated RAW264.7 macrophages [57]. Furthermore, 
bavachin, bavachinin, corylin, corylifol, neobavaisoflavone, and isobavachalcon exert 
inhibitory effects of IL-6-triggered signal transducer and activator of transcription 3 
(STAT3) in Hep3B hepatoma cells [58]. The flavonoids which are derived from 
Psoralea corylifolia L. exhibit potentially inhibitory effects on inflammation. 
Nevertheless, the anti-inflammatory effects of flavonoids of Psoralea corylifolia L. in 
LPS-induced inflammation are unclear. 
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1.5 Research purpose 
The LPS-induced inflammation is widely associated with pathogenesis of several 
diseases. Especially, it might cause systemic inflammatory response syndrome, sepsis, 
multiple organ failure, and even death. At present, there are no specific therapeutic 
agents or supplementation on treatment of exercise-induced endotoxemia. A part of 
NSAIDs (aspirin and ibuprofen) improve exercise-induced hyperthermia, but increase 
permeability of intestine [35]. On the other hand, the probiotic supplementation reduces 
exercise-induced intestinal barrier dysfunction, but does not affect exercise-induced 
inflammation [36, 37]. In previous studies, the polyphenols which derived from herbs, 
fruits, and vegetables inhibit LPS-induced production of pro-inflammatory mediators 
and cytokines, as well as exert protection against sepsis [40, 41]. Thus, the polyphenols 
which are isolated from Camellia sinensis (L.) O. Kuntze and Psoralea corylifolia L. 
might exert anti-inflammatory effects on LPS-induced inflammation. 
 
The research purpose of this thesis is to investigate the anti-inflammatory effects of 
polyphenols which are isolated from Camellia sinensis (L.) O. Kuntze and Psoralea 
corylifolia L. by LPS-activated macrophages (murine peritoneal macrophages, RAW264 
cells, J774A.1 cells and RAW264.7 cells) (ex vivo and in vitro), and then select 
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candidate compounds. The candidate compounds are supposed to confirm the 
anti-inflammatory effects on LPS-challenged mice (in vivo). 
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Chapter 2. The anti-inflammatory effects of green tea polyphenols in LPS-induced 
inflammation 
2.1 Introduction of green tea polyphenols (Camellia sinensis (L.) O. Kuntze) 
It has been reported that polyphenols of green tea (Camellia sinensis) have health 
benefits in preventing lifestyle-related diseases such cardiovascular diseases and cancers 
[59-61]. The polyphenols are isolated from green tea are (+)-catechin (C), 
(-)-epicatechin (EC), (+) gallocatechin (GC), (-)-epigallocatechin (EGC), 
(+)-gallocatechin gallate (GCG), (-)-epicatechin gallate (ECG) and EGCG. Additionally, 
(-)-catechin is the negative form of (+)-catechin. Furthermore, gallic acid is phenolic 
acid whose structure is similar to pyrogallol, and also isolated from green tea. Among 
major green tea polyphenols, EGC, ECG, and EGCG are polyphenols with 
pyrogallol-type structure. In contrast, (+)-catechin, (-)-catechin and (-)-epicatechin are 
polyphenols without pyrogallol-type structure. It has been found that the pyrogallol-type 
polyphenols increase the macrophage phagocytic activity [62], and are recognized by 
cell-surface receptor, 67-kDa laminin receptor [63, 64]. 
 
In previous studies, EGCG decreased the production of NO, TNF-α and IL-6 through 
suppressing the activation of MAPKs and NF-κB by LPS-activated macrophages [50, 
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65, 66]. However, the anti-inflammatory effects of other polyphenols of green tea 
remain unclear, especially, the gallic acid and polyphenols without pyrogallol-type 
structure ((-)-catechin, (+)-catechin, and (-)-epicatechin). The structure characters of 
catechin (flavon-3-ol) with pyrogallol-type structure (EGCG), catechin without 
pyrogallol-type structure ((-)-catechin, (+)-catechin, and (-)-epicatechin) and 
pyrogallol-type structure (gallic acid) were investigated in this chapter. 
 
2.2 Methods 
Reagents 
The gallic acid (monohydrate) and (-)-catechin were purchased from Wako Chemicals 
(Osaka, Japan). The (+)-catechin (hydrate), (-)-epicatechin, EGCG and LPS (from 
Escherichia coli O55: B5) were obtained from Sigma-Aldrich (St. Louis, USA). 
Phosphate-buffered saline (PBS) was purchased from Gibco-BRL (Life Technologies, 
Grand Island, USA). The p38 MAPK, phospho-p38 MAPK and β-actin antibodies were 
purchased from Cell Signaling Technology, Inc. (Beverly, USA). 
 
Cell culture 
Murine macrophage cell line, RAW264 cells were purchased from European Collection 
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of Cell Culture (ECACC, Salisbury, UK) and were cultured in DMEM with 10% FBS 
(HyClone, Logan, USA) in humidified incubator containing 5% CO2 at 37 ˚C and 
maintained growth by passaged every other day. 
 
Cytokine measurement 
Cells were seeded on at a concentration of 1.45 × 106 cells/mL in 6-well plates, and 
were allowed to acclimate. After 24 h, cells were treated with or without gallic acid, 
(+)-catechin, (-)-catechin, (-)-epicatechin and EGCG (1 and 10 μM) for 4 h. After 4 h, 
cell culture supernatant was removed, and cells were washed with PBS prior to LPS (50 
ng/mL) treatment. After 24 h, the supernatant was collected. The production of TNF-α 
and IL-6 were measured by enzyme-linked immunosorbent assay (ELISA). The 
supernatant was used for the quantification of cytokine concentration by ELISA (R&D 
Systems, Minneapolis, USA) according to the manufacturer’s instruction. 
 
Total protein analysis 
The total protein of the cells was used to detect the effects of green tea polyphenols on 
cell growth/viability [67]. Cells were lysed in radioimmunoprecipitation assay (RIPA) 
buffer (Thermo Scientific, Rockford, USA), and the cell lysates were centrifuged at 
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16,000 g for 20 min at 4 ˚C, and the supernatant was collected as whole cell protein. 
The whole cell protein was used for the determination of protein concentration using the 
micro-bicinchoninic acid (BCA) assay (Thermo Scientific, Rockford, USA), according 
to the manufacturer’s instruction. 
 
Western blotting 
The whole cell proteins were separated by 10% SDS-PAGEs, and transferred onto 
PVDF membranes. The protein expression levels were analyzed using antibodies 
against phospho-p38 MAPK, and p38 MAPK (Cell Signaling, Beverly, USA). The 
protein bands were developed by using ECL Prime Western Blotting Detection Reagent 
(GE Healthcare, Little Chalfont, U.K.), and intensities were quantified using ImageJ 
software (NIH, Bethesda, USA). 
 
Statistical analysis 
All data are expressed as means ± standard error of the mean (SEM). Each value is the 
mean of three independent experiments. SPSS V22.0 (IBM, Tokyo, Japan) was used to 
determine the p values using two-way ANOVA followed by Bonferroni post-hoc tests. 
The p values of <0.05 were considered statistically significant. 
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2.3 Results and figures 
Gallic acid and EGCG increased LPS-repressed cell growth/viability by RAW264 cells 
RAW264 cells were treated with or without gallic acid, (+)-catechin, (-)-catechin, 
(-)-epicatechin and EGCG (1 and 10 μM) for 4 h prior to LPS (50 ng/mL) treatment for 
24 h. As shown in Fig. 3, the total protein of cells was reduced by LPS treatment for 24 
h. The treatment of 10 μM gallic acid and EGCG significantly prevented the repression 
in total protein of LPS-activated RAW264 cells (p<0.05) (Fig. 3). The treatment with 10 
μM (-)-catechin also exhibited the similar effect, but it was not significant (p=0.07). The 
treatment of 10 μM EGCG was significantly more effective than the treatment with 10 
μM (+)-catechin for preserving cell viability (p<0.05) (Fig. 3). 
 
Gallic acid, (-)-catechin and EGCG decreased LPS-induced production of TNF-α and 
IL-6 by RAW264 cells 
RAW264 cells were treated with or without gallic acid, (+)-catechin, (-)-catechin, 
(-)-epicatechin and EGCG (1 and 10 μM) for 4 h prior to LPS (50 ng/mL) treatment for 
24 h. Both treatment with EGCG (1 and 10 μM) decreased the production of TNF-α by 
LPS-activated RAW264 cells significantly as shown in Fig. 4A (p<0.05). The treatment 
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with (-)-catechin (1 and 10 μM) also significantly reduced the production of TNF-α 
(p<0.05). Furthermore, the treatment with gallic acid (10 μM) significantly inhibited the 
production of TNF-α (p<0.05). At the concentration of 10 μM, production of TNF-α 
was greater in response to treatment with (+)-catechin and epicatechin compared with 
EGCG (p<0.05). The treatment with EGCG (1 and 10 μM) and (-)-catechin (1 and 10 
μM) suppressed the production of IL-6 by LPS-activated RAW264 cells (p<0.05) (Fig. 
4B). The treatment with gallic acid (10 μM) also suppressed IL-6 production (p<0.05) 
(Fig. 4B). 
 
The polyphenols with a flavan-3-ol structure affected p38 MAPK 
RAW264 cells were treated with or without gallic acid, (+)-catechin, (-)-catechin, 
(-)-epicatechin and EGCG (10 μM) for 4 h prior to LPS (50 ng/mL) treatment for 45 
min and 2 h. LPS-induced production and phosphorylation of p38 MAPK was increased 
at 45 min (early stage), but after LPS treatment for 2 h (late stage) was decreased 
compared with LPS treatment for 45 min. As shown in Fig. 5, the treatment with 
(+)-catechin, (-)-catechin, (-)-epicatechin and EGCG enhanced phosphorylation and 
total expression of p38 MAPK after LPS treatment for 45 min. By contrast, 
phosphorylation and total expression of p38 MAPK were suppressed after LPS 
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treatment for 2 h. After LPS treatment for both 45 min and 2 h, gallic acid neither 
enhanced nor suppressed production and phosphorylation of p38 MAPK. 
Fig. 3. The effects of green tea polyphenols on cell growth/viability by RAW264 
cells. Cells were treated with polyphenols of green tea for 4 h, and then washed cells 
with PBS prior to LPS (50 ng/ml) treatment for 24 h. The open bar: without treatment of 
polyphenols and LPS challenge. The close bar: without treatment with polyphenols. 
Each column represents the mean ± SEM from three independent experiments. ##: 
p<0.01 versus the negative control. **: p<0.01 versus the pre-treatment without 
polyphenol of green tea. +: p<0.05 versus the same concentration of EGCG. 
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Fig. 4. The effects of green tea polyphenols on LPS-induced TNF-α and IL-6 
production by RAW264 cells. Cells were treated with polyphenols of green tea for 4 h, 
and then washed cells with PBS prior to LPS (50 ng/ml) treatment for 24 h. The 
concentration of (A) TNF-α and (B) IL-6 in the supernatant. The close bar: without 
pretreatment with polyphenols. Each column represents the mean ± SEM from three 
independent experiments. *: p<0.05, **: p<0.01 versus the pre-treatment without 
polyphenol of green tea. ++: p<0.01 versus the same concentration of EGCG. 
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Fig. 5. The effects of green tea polyphenols on p38 MAPK by LPS-activated 
RAW264 cells. NC, negative control; LPS, stimulated with LPS (50 ng/ml) and without 
treatment of polyphenol; GA, treatment with gallic acid 4 h; (+), treatment with 
(+)-catechin 4 h; (-), treatment with (-)-catechin 4 h; Epi, treatment with (-)-epicatechin 
4 h; EGCG, treatment with EGCG 4 h. 
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2.4 Discussion 
The cell death and apoptosis of macrophages are increased by LPS stimulation [68-70]. 
Our results indicated that LPS decreased cell growth/viability (whole cell protein 
expression). The treatment with EGCG and gallic acid increased cell growth/viability 
compare with LPS alone. Interestingly, the treatment with (+)-catechin, (-)-catechin and 
(-)-epicatechin did not affect LPS-induced reduction of cell growth/viability. Taken 
together, these results suggest that pyrogollol-type polyphenols might protect the cell 
growth/viability against the effects of LPS stimulation in macrophages. 
 
In a previous study, EGCG exerted anti-inflammatory effects on LPS-activated 
macrophages [50]. Our results also demonstrated that EGCG had the most powerful 
anti-inflammatory effects compared with other green tea polyphenols. The polyphenols 
of green tea with pyrogallol-type structure, such as gallic acid and EGCG exerted 
anti-inflammatory effect on LPS-activated RAW264 cells. Interestingly, (-)-catechin is a 
polyphenol in green tea without pyrogallol-type structure, but also repressed the 
production of TNF-α and IL-6 of LPS-stimulated RAW264 cells. In the previous study, 
Singh et al. demonstrated that catechin attenuated the production of TNF-α by 
LPS-activated human monocytic cell line THP-1 cells [66]. The form of catechin 
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includes (-)-catechin, (+)-catechin, and (±)-catechin hydrate. The form of catechin 
which was investigated in this previous study was not explained. It might be 
(-)-catechin or (±)-catechin hydrate, not (+)-catechin. 
 
LPS increased both phosphorylation and total expression of p38 MAPK in the early 
stage, whereas it was diminished in the late stage [71, 72]. Our results demonstrated that 
polyphenols with a flavan-3-ol structure regulated phosphorylation and total expression 
of p38 MAPK by LPS-activated macrophages, but gallic acid neither enhanced nor 
attenuated phosphorylation and total expression of p38 MAPK. It suggests that the 
anti-inflammatory effects of gallic acid on LPS-stimulated RAW264 cells are not 
through regulation of p38 MAPK. 
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Chapter 3. The anti-inflammatory effects of bavachin in LPS-induced 
inflammation 
3.1 Introduction of bavachin (Psoralea corylifolia L. (Fabaceae)) 
Bavachin is a flavonoid which is derived from the seed and fruit of Psoralea corylifolia 
L. [55, 73]. Bavachin is a selective estrogen-receptor modulator which regulates the 
activation of estrogen receptors ERα and ERβ [74]. Accordingly, bavachin improves 
estrogen deficiency-induced osteoporosis and activates proliferation of osteoblasts [75]. 
Bavachin enhances glucose uptake of adipocyte 3T3-L1 cells [76]. Notably, bavachin 
suppresses IL-6-triggered activation and phosphorylation of STAT3 in hepatoma Hep3B 
cells [58], reduces IL-1β-induced NF-κB activity and chemokine production in 
chondrocyte CHON-002 cells, and inhibits IL-1β-induced migration in monocyte 
THP-1 cells [56]. However, the anti-inflammatory effects of bavachin on LPS-induced 
inflammation are unclear. 
 
3.2 Methods 
Ethics statement 
The experiments in this chapter were carried out in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory Animals of the 
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National Institutes of Health. The animal care and experimental protocols were accepted 
by the Committee on the Ethics of Animal Experiments of the Kaohsiung Medical 
University (Permit Number: 104092). 
 
Reagents 
Bavachin was obtained from ChemFaces (Wuhan, China), and confirmed the endotoxin 
levels using limulus amebocyte lysate single test (Associates of Cape Cod, Inc., 
Falmouth, USA). The endotoxin levels in bavachin were fewer than 0.03 EU/mL. All 
cell culture reagents were obtained from Gibco-BRL (Life Technologies, Grand Island, 
USA). 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT), 
phosphatase inhibitor cocktail, protease inhibitor cocktail, Griess reagent, trypan blue, 
thioglycollate medium, LPS (from Escherichia coli O111:B4), RIPA buffer and PBS 
were purchased from Sigma Aldrich (St. Louis, USA). BCA assay, ECL 
chemiluminescence substrate and stripping buffer were purchased from Thermo 
Scientific (Waltham, USA). For Western blotting, rabbit antibodies against mouse 
phospho-JNK 1/2, JNK 1/2, phospho-ERK 1/2, ERK 1/2, phospho-p38 MAPK, p38 
MAPK and NLRP3 were purchased from Cell Signaling (Farmingdale, USA). Mouse 
antibody against caspase-1 (p20) was purchased from Adipogen (San Diego, USA). 
37 
 
Mouse antibody against β-tubulin was purchased from Thermo Scientific (Waltham, 
USA). Rabbit antibodies against mouse ASC, IL-1β, iNOS, COX-2, and secondary 
antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, USA). Rabbit 
antibody against mouse mPGES-1 and PGE2 ELISA kit were purchased from Cayman 
Chemical Company (Ann Arbor, USA). IL-1β, IL-6 and IL-12p40 ELISA kits were 
purchased from eBioscience (San Diego, USA). 
 
Cell culture 
Murine macrophage cell line J774A.1 cells were obtained from Bioresource Collection 
and Research Center (Food Industry Research and Development Institute, Hsinchu, 
Taiwan), and were cultured in RPMI-1640 medium with 10% FBS, penicillin (100 
units/mL) and streptomycin (100 units/mL) and passaged every other day to maintain 
growth at 37 ˚C in humidified incubator containing 5% CO2. Murine peritoneal 
macrophages were harvested from C57BL/6 mice. The specific pathogen-free female 
C57BL/6 mice were obtained from the BioLASCO Taiwan., Co. Ltd (Taipei, Taiwan). 
The female C57BL/6 mice (6~8 week of age) were intraperitoneally injected with 1 mL 
sterile 3% thioglycollate medium and peritoneal macrophages were harvested after 4 d. 
The peritoneal macrophages were confirmed 95% viability using trypan blue dye 
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exclusion assay, and were re-suspended in RPMI-1640 medium. The cells were seeded 
at a concentration of 1 × 106 cells/mL in 96-well plates to allow macrophage adherence 
at 37 ˚C in a humidified incubator containing 5% CO2. 
 
NO determination and cell viability 
J774A.1 cells and murine peritoneal macrophages were seeded at a concentration of 1 × 
106 cells/mL in 96-well plates. The cells were treated with bavachin (0, 10, 20, 30 and 
40 μM) for 1 h prior to LPS (1 μg/mL) treatment. After 24 h, the supernatant was 
harvested and the NO concentration was measured using the Griess reagent according to 
the manufacturer’s instruction (Sigma Aldrich, St. Louis, USA). The cells were 
incubated with MTT at 37 ˚C for 4 h, and then lysed with isopropanol. The cell viability 
was analyzed by estimating the OD at 570 nm. 
 
Cytokine measurement 
J774A.1 cells and murine peritoneal macrophages were seeded at a concentration of 1 × 
106 cells/mL in 96-well plates, and were allowed to acclimatize overnight. The cells 
were treated with of bavachin (0, 10, 20, 30 and 40 μM) for 1 h prior to LPS (1 μg/mL) 
treatment for 24 h. The supernatant was used for quantification of PGE2, IL-6 and 
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IL-12p40 concentrations by ELISA according to the manufacturer’s protocols (PGE2: 
Cayman Chemical Company, Ann Arbor, USA) (IL-6 and IL-12p40: eBioscience, San 
Diego, USA). 
 
NF-κB promoter reporter assay 
J774A.1 cells were stably transfected with pNiFty2-SEAP plasmids which carry a 
reporter gene induced by NF-κB, and secrete embryonic alkaline phosphatase (SEAP). 
These cells are called J-Blue cells [77]. J-Blue cells were cultured in RPMI-1640 
medium supplemented with Zeocin (200 μg/mL) (InvivoGen, San Diego, USA). Cells 
were seeded at a concentration of 1 × 106 cells/mL in 96-well plates, and were allowed 
to acclimatize overnight, and then treated with bavachin (0, 20 and 40 μM) for 1 h prior 
to LPS (1 μg/mL) treatment for 24 h. The supernatant was mixed with QUANTI-Blue 
medium (InvivoGen, San Diego, USA) and incubated at 37 ˚C for 45 min. SEAP 
activity was assessed by measuring the OD at 655 nm. 
 
NLRP3 inflammasome experiment 
J774A.1 cells were seeded at a concentration of 1 × 106 cells/mL in 6-well plates, and 
were allowed to acclimatize overnight. The cells were treated with LPS (1 μg/mL) for 5 
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h, and then treated with bavachin (0, 10, 20, 30 and 40 μM) for 1 h following treatment 
of ATP (5 mM) for 30 min. The supernatant was harvested and the concentration of 
IL-1β was measured using ELISA according to the manufacturer’s instructions 
(eBioscience, San Diego, USA), and the cell lysate was used for analysis of NLRP3 
inflammasome protein levels by Western blotting. 
 
Western blotting 
The whole cell proteins were separated on 8~15% SDS-PAGEs and were transferred 
onto PVDF membranes. The protein expression levels were detected using antibodies 
against phospho-JNK 1/2, JNK 1/2, phospho-ERK 1/2, ERK 1/2, phospho-p38 MAPK, 
p38 MAPK, iNOS, mPGES-1, COX-2, NLRP3, ASC, IL-1β, caspase-1 (p20) and 
β-tubulin. The protein band signals were developed by ECL chemiluminescence 
substrate and quantified by Alphaview SA software (Alpha Innotech Corporation, San 
Leandro, CA, USA). 
 
Statistical analysis 
All data are expressed as means ± SD. Each value is the mean of three independent 
experiments. GraphPad Prism 5 (San Diego, CA, USA) was used to determine the p 
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values using one-way ANOVA followed by Tukey post-hoc test, and the significant 
difference was set at *p < 0.05; **p < 0.01. 
 
3.3 Results and figures 
Bavachin suppressed the LPS-induced production of NO and PGE2 by J774A.1 cells 
To confirm the effect of bavachin on the cell viability of J774A.1 cells, the cells were 
treated with bavachin (0~40 μM) for 1 h prior to LPS (1 μg/mL) treatment for 24 h. The 
treatment of bavachin (0~40 μM) did not affect the cell viability (Fig. 6A). To avoid the 
cytotoxicity of bavachin, the maximum concentration of bavachin used in the following 
experiments was 40 μM. To examine the effects of bavachin on NO and PGE2, in 
LPS-activated J774A.1 cells, the cells were treated with bavachin (0~40 μM) for 1 h, 
and then treated with LPS (1 μg/mL) for 24 h. These results indicated that bavachin 
significantly decreased the production of NO and PGE2 by LPS-stimulated J774A.1 
cells in a concentration-dependent manner (Fig. 6B and C). 
 
Bavachin reduced LPS-induced the expression of iNOS and mPGES-1, but did not affect 
the expression of COX-2 
NO is synthesized by iNOS, and PGE2 is converted by COX-2 and mPGES-1 in 
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LPS-activated macrophages. For the reason that bavachin decreased LPS-induced NO 
and PGE2 production, the effects of bavachin on the expression levels of iNOS, COX-2 
and mPEGS-1 in LPS-activated J774A.1 cells were treated with bavachin (0, 20 and 40 
μM) for 1 h prior to with or without LPS (1 μg/mL) treatment for 16 h. LPS increased 
the expression levels of iNOS, COX-2 and mPGES-1 dramatically. Additionally, 
bavachin suppressed the LPS-induced expression of iNOS and mPGES-1 
concentration-dependently, but did not affect the expression of COX-2 (Fig. 7 A and B). 
 
Bavachin decreased LPS-induced production of IL-6 and IL-12p40 by J774A.1 cells 
To examine the effects of bavachin on LPS-induced production of IL-6 and IL-12p40, 
J774A.1 cells were treated with bavachin (0~40 μM) for 1 h prior to LPS (1 μg/mL) 
treatment for 24 h. The treatment of bavachin at 40 μM significantly decreased the 
production of IL-6 and IL-12p40 production (Fig. 8A and B). 
 
Bavachin suppressed LPS-stimulated phosphorylation of JNK 1/2 and ERK 1/2, but did 
not affect the phosphorylation of p38 MAPK 
To investigate the effect of bavachin on LPS-induced MAPKs activation, cells were 
treated with bavachin (0, 20 and 40 μM) for 1 h prior to with or without LPS (1 μg/mL) 
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treatment for 1 h. LPS markedly increased the phosphorylation levels of JNK 1/2, ERK 
1/2 and p38 MAPK. Furthermore, bavachin significantly inhibited LPS-induced 
phosphorylation of JNK 1/2 and ERK 1/2, but not p38 MAPK (Fig. 9A and B). 
 
Bavachin suppressed LPS-induced activation of NF-κB by J-Blue cells 
To confirm the effect of bavachin on NF-κB activity by detection of SEAP activity, 
J-Blue cells were treated with bavachin (0, 20 and 40 μM) for 1 h prior to with or 
without LPS (1 μg/mL) treatment for 24 h. LPS increased approximately 3-fold NF-κB 
activity. Additionally, bavachin significantly suppressed LPS-induced NF-κB activity at 
both 20 μM and 40 μM (Fig. 9C). 
 
Bavachin inhibited NLRP3 inflammasome-derived IL-1β production and caspase-1 
activation 
To investigate the effects of bavachin on NLRP3 inflammasome-derived IL-1β 
production and NLRP3 inflammasome complex formation, cells were treated with or 
without of LPS (1 μg/mL) for 5 h, and then treated with bavachin (0~40 μM) for 1 h 
following treatment of ATP (5 mM) for 30 min. The experimental results showed that 
the production of IL-1β was markedly increased by ATP-activated NLRP3 
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inflammasome. Bavachin significantly reduced NLRP3 inflammasome-primed 
production of IL-1β concentration-dependently (Fig. 10A). In addition, ATP-activated 
NLRP3 inflammasome increased the active form of caspase-1 p20 protein expression 
level. Bavachin decreased the expression of caspase-1 p20 and mature IL-1β protein 
(Fig. 10B). 
 
Bavachin reduced the production of NO, IL-6 and IL-12p40 by murine peritoneal 
macrophages 
To examine the effects of bavachin in LPS-stimulated murine peritoneal macrophages, 
cells were treated with bavachin (0~40 μM) for 1 h prior to with or without LPS (1 
μg/mL) treatment for 24 h. The experimental results indicated there was no toxic effect 
of bavachin treatment on the cell viability (Fig. 11A). Subsequently, bavachin 
significantly suppressed LPS-induced production of NO, IL-6 and IL-12p40 by 
LPS-activated murine peritoneal macrophages concentration-dependently (Figure 11B, 
C and D). 
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Fig. 6. The effects of bavachin on the cell viability and the production of NO and 
PGE2 by LPS-stimulated J774A.1 cells. Cells were treated with bavachin (0~40 μM) 
for 1 h prior to LPS (1 μg/mL) treatment for 24 h. (A) The cell viability. (B) The 
concentration of NO and (C) PGE2 in the supernatant. The data are presented as means 
± SD of three independent experiments. Statistical significance was represented as 
follows: * p< 0.05 and ** p< 0.01 vs LPS alone. 
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Fig. 7. The effects of bavachin on the expression of iNOS, COX-2 and mPGES-1 by 
LPS-activated J774A.1 cells. Cells were treated with different bavachin (0, 20 and 40 
μM) for 1 h prior to LPS (1 μg/mL) treatment. After 16 h, cell lysates were harvested. 
(A) The representative of Western blotting results was obtained in three separate 
experiments. (B) The intensities of bands were quantified from three separate 
experiments and normalized to untreated samples. The data are presented as means ± 
SD of three independent experiments. Statistical significance was represented as 
follows: * p< 0.05 vs LPS alone. 
47 
 
Fig. 8. The effects of bavachin on the production of IL-6 and IL-12p40 by 
LPS-stimulated J774A.1 cells. Cells were treated with bavachin (0~40 μM) for 1 h 
prior to LPS (1 μg/mL) treatment for 24 h. The supernatant was collected. The 
concentrations of (A) IL-6 and (B) IL-12p40 in the supernatant. The data are presented 
as means ± SD of three independent experiments. Statistical significance was 
represented as follows: * p< 0.05 vs LPS alone. 
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Fig. 9. The effects of bavachin on the activation of MAPKs by LPS-stimulated 
J774A.1 cells, and the activity of NF-κB in LPS-stimulated J-Blue cells. J774A.1 
cells were treated with bavachin (0, 20 and 40 μM) for 1 h prior to LPS (1 μg/mL) 
treatment for 1 h. (A) The expression levels of p-JNK 1/2, JNK 1/2, p-ERK 1/2, ERK 
1/2, p-p38 MAPK and p38 MAPK. The representative of Western blotting results was 
shown. (B) The intensities of bands were quantified from three separate experiments 
and normalized to untreated samples. (C) J-Blue cells were treated with bavachin (0, 20 
and 40 μM) for 1 h prior to LPS (1 μg/mL) treatment for 24 h. The supernatant was 
collected for SEAP activity assay. The data are presented as means ± SD of three 
independent experiments. Statistical significance was represented as follows: * p< 0.05 
and ** p< 0.01 vs LPS alone. 
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Fig. 10. The effects of bavachin on the production of IL-β and the expression of 
NLRP3 inflammasome complex. J774A.1 cells were treated with LPS (0 and 1 
μg/mL) for 5 h, and then treated with bavachin (0~40 μM) for 1 h following treatment 
of ATP (5 mM) for 30 min. (A) The concentration of IL-1β in the supernatant. The data 
are presented as means ± SD of three independent experiments. Statistical significance 
was represented as follows: * p< 0.05 and ** p< 0.01 vs LPS plus ATP alone. (B) The 
expression levels of NLRP3, ASC, capase-1, IL-1β and β-tubulin were analyzed using 
Western blotting. 
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Fig. 11. The effects of bavachin on the production of NO, IL-6 and IL-12p40 by 
LPS-stimulated murine peritoneal macrophages. Cells were treated with bavachin 
(0~40 μM) for 1 h prior to LPS (1 μg/mL) treatment for 24 h. (A) The cell viability. (B) 
The concentration of NO, (C) IL-6 and (D) IL-12p40 in the supernatant. The data are 
presented as means ± SD of three independent experiments. Statistical significance was 
represented as follows: * p< 0.05 and ** p< 0.01 vs LPS alone. 
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3.4 Discussion 
These experimental results demonstrated that bavachin which a flavonoid is derived 
from Psoralea corylifolia L. decreased LPS-stimulated production of PGE2 and NO via 
the inhibitory effects on mPGES-1 and iNOS. In addition, bavachin suppressed 
LPS-induced IL-6 and IL-12p40 production, and inhibited MAPKs and NF-κB 
activation. On the other hand, bavachin suppressed NLRP3 inflammasome-primed 
IL-1β production and reduced caspase-1 activation and mature IL-1β protein expression 
level. Moreover, bavachin also reduced the production of NO, IL-6 and IL-12p40 in 
LPS-stimulated murine peritoneal macrophages. 
 
iNOS catalyzes the reaction in which L-Arginine converts to NO, and NO is oxidized to 
cytotoxic ONOO- by O2-. Overproduction of NO leads to tissue destruction in several 
inflammatory diseases [78]. Bavachin not only decreased LPS-induced NO production 
by J774A.1 cells, but also exerted inhibitory effect on LPS-induced NO production by 
murine peritoneal macrophages. The experimental results suggested that bavachin 
suppressed LPS-induced production of NO through decreasing iNOS expression. 
 
PGE2 crucially contributes to edema, fever and pain, and increases vascular 
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permeability and immune cell infiltration. The process of PGE2 synthesis is COX-2 
transforms AA to PGH2, and then mPGES-1 converts PGH2 to PGE2 [23]. These results 
indicated that bavachin inhibited LPS-induced PGE2 production and mPGES-1 
expression, but did not decrease COX-2 expression. Thus, it suggests that bavachin 
reduces the PGE2 production through inhibitory effect on mPGES-1 (PGH2 converts to 
PGE2), not COX-2 (AA converts to PGH2). 
 
IL-6/IL-12 family includes several similar structure in cytokines which share the 
subunits to induce inflammation and regulate adaptive immune system [26]. IL-6 elicits 
activity of B and T cells [25], and IL-12 induces T-cell differentiation [79]. Our results 
demonstrated that bavachin not only suppressed LPS-induced IL-6 and IL-12p40 
production by J774A.1 cells, but also exerted inhibitory effects on IL-6 and IL-12p40 
production by LPS-activated murine peritoneal macrophages. Taken together, bavachin 
reduced pro-inflammatory cytokine IL-6 and IL-12p40 by LPS-activated macrophages. 
 
IL-1β is considered that is a critical contributor to several immune-related diseases. 
NLRP3 inflammasome crucially contribute to prime mature IL-1β, and is associated 
with pathogenesis of several immune-related diseases [12]. Our results indicated that 
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bavachin inhibited NLRP3 inflammasome-primed caspase-1 activation and IL-1β 
production. It is suggested that bavachin is a potentially anti-inflammatory supplement 
candidates in the treatment of these immune-related diseases. 
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Chapter 4. The anti-inflammatory effects of corylin in LPS-induced inflammation 
4.1 Introduction of corylin (Psoralea corylifolia L. (Fabaceae)) 
Corylin is another flavonoid which derived from Psoralea corylifolia L. [52, 55]. It has 
been reported that corylin exerts antioxidant activities [80] and increases osteoblastic 
proliferation in UMR106 cells [81]. In addition, corylin suppresses IL-6-triggered 
STAT3 activation in Hep3B cells [58]. Nevertheless, the effects of corylin on 
LPS-induced inflammation are unclear. 
 
4.2 Methods 
Ethics statement 
The animal care and experimental protocols were approved by the same committee as 
Chapter 3 (Permit Number: 104092). 
 
Reagents 
Corylin was obtained from ChemFaces (Wuhan, Hubei, PRC), and endotoxin levels in 
corylin were confirmed fewer than 0.03 EU/mL. HMGB1 ELISA kit was obtained from 
Aviva Systems Biology (San Diego, USA). Nuclear protein isolation-translocation assay 
kit was obtained from Fivephoton Biochemicals (San Diego, USA). Mouse antibody 
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against mouse HMBG1 was obtained from OriGene Technologies, Inc. (Rockville, 
USA). Rabbit antibody against mouse Lamin A/C was obtained from GeneTex, Inc. 
(Irvine, USA). The all cell culture, NO determination, cell viability, cytokine 
measurement, NF-κB promoter reporter assay and Western blotting reagents were the 
same as the reagents in Chapter 3. 
 
Cell culture 
Murine macrophage cell line RAW264.7 cells were obtained from Bioresource 
Collection and Research Center (Food Industry Research and Development Institute, 
Hsinchu, Taiwan), and were cultured in RPMI-1640 medium with 10% FBS, penicillin 
(100 units/mL) and streptomycin (100 units/mL) in humidified incubator containing 5% 
CO2 at 37 ˚C and maintained growth by being passaged every other day. In addition, the 
protocols of murine peritoneal macrophage isolation and culture were the same as the 
protocols in Chapter 3. The cells were seeded at a concentration of 1 × 106 cells/mL in 
96-well plates for cell viability, NO determination, and cytokine measurement. 
 
Experimental protocols 
The experimental protocols of cell viability (MTT assay), NO determination (Griess 
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reagent), cytokine measurement (ELISA), NF-κB promoter reporter assay (J-Blue cells) 
and Western blotting were the same as the experimental protocols in Chapter 3. 
 
LPS-induced systemic inflammation and sepsis mouse model 
The experiments were carried out in the following groups: DMSO group (vehicle 
control), LPS group (LPS plus DMSO); LPS plus corylin (20 mg/kg body weight) 
group and LPS plus corylin (40 mg/kg body weight). Mice were intraperitoneally 
administered with DMSO or corylin. After 1 h, experimental systemic inflammation and 
sepsis were induced by intraperitoneally injecting LPS (50 mg/kg body weight). The 
mouse serum samples were harvested for 4 h after LPS administration for the 
measurement of NO and TNF-α. Survival was monitored for 120 h after LPS 
administration. 
 
Histopathology and Biochemistry analysis 
Mice were intraperitoneally injected with DMSO or corylin. After 1 h, experimental 
sepsis was induced by intraperitoneally injecting LPS (50 mg/kg body weight). After 
LPS administration for 20 h, tissues were harvested and fixed with 4% formaldehyde 
solution, and then embedded in paraffin and sectioned. The tissue sections were 
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counterstained with hematoxylin and eosin (H&E). The mouse blood samples were 
harvested and quantified the activities of Aspartate Aminotransferase (AST), Alanine 
Aminotransferase (ALT), creatinine (CRE) and blood urea nitrogen (BUN). 
 
Statistical analysis 
All data are expressed as means ± standard deviation (SD). Each value is the mean of 
three independent experiments. GraphPad Prism 5 (San Diego, CA, USA) was used to 
determine the p values using one-way ANOVA followed by Tukey post-hoc test, and 
survival analysis was performed using Log-Rank test. The significant difference was set 
at *p < 0.05; **p < 0.01. 
 
4.3 Results, figures and tables 
Corylin inhibited LPS-induced PGE2 and NO production and COX-2 and iNOS 
expression by RAW264.7 cells 
To elude the cytotoxicity of corylin, RAW264.7 cells were treated with corylin (0, 2.5, 5, 
10 and 20 μM) for 1 h prior to LPS (1 μg/ml) treatment for 24 h. The results indicated 
that all concentration of corylin treatment did not affect cell viability (Fig. 12A). To 
examine the effect of corylin on LPS-induced production of NO and PGE2, cells were 
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treated with corylin (0, 2.5, 5, 10 and 20 μM) for 1 h prior to LPS (1 μg/ml) treatment 
for 24 h. Corylin dramatically reduced LPS-induced production of PGE2 and NO (Fig. 
12B and C). Additionally, corylin reduced LPS-induced expression of COX-2 and iNOS 
(Fig. 12D). 
 
Corylin suppressed LPS-induced production of TNF-α, IL-6 and HMGB1 in RAW264.7 
cells 
RAW264.7 cells were treated with corylin (0, 2.5, 5, 10 and 20 μM) for 1 h prior to LPS 
(1 μg/ml) treatment for 24 h. Corylin reduced LPS-stimulated production of TNF-α, 
IL-6 and HMGB1 concentration-dependently (Fig. 13A, B and C). In addition, LPS 
increased translocation of nucleus HMGB1 into cytoplasm. Corylin inhibited 
LPS-induced translocation of nucleus HMGB1 (Fig. 13D). 
 
Corylin suppressed LPS-induced phosphorylation of MAPKs by RAW264.7 cells, and 
LPS-induced activation of NF-κB in J-Blue cells. 
These experimental results indicated that LPS dramatically increased phosphorylation 
of MAPKs, and corylin significantly reduced LPS-stimulated phosphorylation of 
MAPKs (Fig. 14A and B). In addition, activation of NF-κB was markedly increased by 
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LPS, and corylin also significantly suppressed LPS-induced NF-κB activity by J-Blue 
cells (Fig. 14C). 
 
Corylin exerted inhibitory effects on LPS-induced production of NO, TNF-α and IL-6 in 
murine peritoneal macrophages 
To confirm the effects of corylin in LPS-stimulated murine peritoneal macrophages, 
cells were treated with corylin (0, 2.5, 5, 10 and 20 μM) for 1 h prior to LPS (1 μg/ml) 
treatment for 24 h. As shown in Fig. 15A, the results indicated that all concentrations of 
corylin treatment did not affect cell viability of murine peritoneal macrophages. 
Additionally, corylin dramatically reduced LPS-induced production of NO, TNF-α and 
IL-6 ex vivo (Fig. 15B, C and D). 
 
Corylin repressed LPS-induced tissue damage in LPS-treated mice 
Mice were intraperitoneally administered with DMSO or corylin. After 1 h, 
experimental systemic inflammation and sepsis were induced by intraperitoneally 
injecting LPS (50 mg/kg body weight). After LPS administration for 20 h, lung, liver 
and kidney were damaged by LPS-induced systemic inflammation. It was observed that 
the alveolar wall swelling was augmented, and pulmonary alveoli were decreased in 
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LPS-stimulated lung damage. The treatment of corylin improved the alveolar wall 
swelling, and increased the LPS-declined the pulmonary alveolus. On LPS-induced 
liver damage, the treatment of corylin repressed LPS-induced cavities of liver tissue and 
infiltration of inflammatory cells. On LPS-induced kidney damage, it decreased brush 
borders and renal epithelial cells, and exhibited that renal tubular epithelial cells were 
sloughed in LPS-challenged mice. The treatment of corylin inhibited LPS-induced 
decreases in epithelial cells and brush borders, and reduced the sloughing of tubular 
epithelial cells in kidney (Fig. 16). In addition, AST, ALT, BUN and CRE were 
dramatically elevated by LPS administration. The treatment of corylin significantly 
decreased LPS-induced increases in AST, ALT, BUN and CRE (Tab. 1). 
 
Corylin reduced the production of NO and TNF-α in serum, and increased the survival 
rate of LPS-treated mice 
Mice were intraperitoneally administered with DMSO or corylin. After 1 h, 
experimental systemic inflammation and sepsis were induced by intraperitoneally 
injecting LPS (50 mg/kg body weight). After LPS administration for 4 h, the blood 
samples were harvested. The survival was monitored for 120 h after LPS administration. 
The results suggested the treatment of corylin reduced the levels of NO and TNF-α in 
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serum after LPS administration (Fig. 17A and B). Furthermore, the treatment of corylin 
increased survival rate significantly (Fig. 17C). 
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Fig. 12. The effects of corylin on LPS-induced PGE2 and NO production, and 
COX-2 and iNOS expression in RAW 264.7 cells. Cells were treated with corylin 
(0~20 μM) for 1 h prior to LPS (1 μg/mL) treatment for 24 h. (A) The cell viability. (B) 
The concentration of PGE2 and (C) NO in the supernatant. Cells were treated with 
corylin (0, 10 μM and 20 μM) for 1 h prior to LPS (1 μg/mL) treatment for 6 h. (D) The 
expression levels of COX-2 and iNOS. (E) The intensities of bands were quantified 
from three separate experiments and normalized to untreated samples. The data are 
presented as means ± SD of three independent experiments. Statistical significance was 
represented as follows: * p< 0.05 vs LPS alone. 
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Fig. 13. The effects of corylin on LPS-induced TNF-α, IL-6 and HMGB1 
production in RAW 264.7 cells. Cells were treated with corylin (0~20 μM) for 1 h 
prior to LPS (1 μg/mL) treatment for 24 h. The concentrations of (A) TNF-α, (B) IL-6 
and (C) HMGB1 in the supernatant. Cells were treated with corylin (0, 10 μM and 20 
μM) for 1 h prior to LPS (1 μg/mL) treatment for 6 h. The data are presented as means ± 
SD of three independent experiments. Statistical significance was represented as 
follows: * p< 0.05 vs LPS alone. (D) The expression of HMGB1 in nucleus and cytosol 
were determined by Western blotting. 
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Fig. 14. The effects of corylin on LPS-induced phosphorylation of JNK 1/2, p38 
MAPK and ERK 1/2 in RAW 264.7 cells and the LPS-induced activation of NF-κB 
in J-Blue cells. Cells were treated with corylin (0, 10 μM and 20 μM) for 1 h prior to 
LPS (1 μg/mL) treatment for 30 min. (A) The expression levels of p-JNK 1/2, JNK 1/2, 
p-ERK 1/2, ERK 1/2, p-p38 MAPK and p38 MAPK. The representative of Western 
blotting results was obtained in three separate experiments. (B) The intensities of bands 
were quantified from three separate experiments and normalized to untreated samples. 
(C) J-Blue cells were treated with corylin (0, 10 and 20 μM) for 1 h prior to LPS (1 
μg/mL) treatment for 24 h. The supernatant was collected for SEAP activity assay. The 
data are presented as means ± SD of three independent experiments. Statistical 
significance was represented as follows: * p< 0.05 and ** p< 0.01 vs LPS alone. 
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Fig. 15. The effects of corylin on LPS-induced NO, TNF-α and IL-6 production in 
murine peritoneal macrophages. Cells were treated with corylin (0~20 μM) for 1 h 
prior to LPS (1 μg/mL) treatment for 24 h. (A) The cell viability. (B) The concentrations 
of NO, (C) TNF-α and (D) IL-6 in the supernatant. The data are presented as means ± 
SD of three independent experiments. Statistical significance was represented as 
follows: * p< 0.05 vs LPS alone. 
 
 
66 
 
Fig. 16. The effects of corylin on LPS-induced tissue damage of lung, liver and 
kidney in mice. Female C57BL/6 mice were treated with DMSO or corylin (20 or 40 
mg/kg, i.p.) for 1 h prior to LPS administration (50 mg/kg, i.p.). After LPS 
administration for 20 h, lung, liver and kidney tissues were harvested. The results show 
H&E-staining (× 200). The red arrows indicate the infiltration of inflammatory cells and 
damage sites. 
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Fig. 17. The effects of corylin on NO and TNF-α concentrations in serum and 
survival rate by LPS-treated mice. Female C57BL/6 mice were treated with DMSO 
or corylin (20 or 40 mg/kg, i.p.) for 1 h prior to LPS administration (50 mg/kg, i.p.). 
After LPS administration for 4 h, the blood samples were collected. The concentration 
of (A) NO and (B) TNF-α in the mouse serum. The data are presented as means ± SD of 
three independent experiments. Statistical significance was represented as follows: * p< 
0.05 and ** p< 0.01 vs LPS alone. (C) The survival was monitored for 120 h (n=10). 
Statistical significance was represented as follows: * p< 0.05 vs DMSO. 
 
 
 
68 
 
Tab. 1. The effects of corylin on LPS-induced liver and kidney damage markers. 
 DMSO LPS Corylin 20 mg/kg Corylin 40 mg/kg 
AST 200.00±3.00 619.75±97.39
**
 333.50±31.25
+
 289.00±34.53
+
 
ALT 46.50±0.50 291.33±85.61
*
 72.40±5.61
+
 69.33±4.18
+
 
BUN 28.40±1.20 150.50±11.93
**
 41.66±5.44
++
 40.3±9.90
++
 
CRE 0.31±0.01 0.93±0.21
**
 0.26±0.04
++
 0.28±0.02
++
 
Female C57BL/6 mice were treated with DMSO or corylin (20 or 40 mg/kg, i.p.) for 1 h 
prior to LPS administration (50 mg/kg, i.p.). After LPS administration for 20 h, the 
blood samples were harvested. The levels of ALT, AST, BUN and CRE were quantified 
(n=5). Statistical significance was represented as follows: *: p<0.05, **: p<0.01 vs 
DMSO; +: p<0.05, ++: p<0.05 vs LPS. 
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4.4 Discussion 
The present results demonstrated that corylin suppressed LPS-stimulated TNF-α, IL-6, 
and NO production by RAW264.7 cells and murine peritoneal macrophages. 
Additionally, corylin decreased LPS-induced production of PGE2 and HMBG1, and 
inhibited LPS-induced expression of iNOS and COX-2 and translocation of nucleus 
HMBG1 by RAW264.7 cells. It is suggested that corylin repressed LPS-induced 
inflammation through inhibitory effects on MAPKs and NF-κB. In LPS-stimulated 
systemic inflammation, the treatment of corylin repressed LPS-induced ALT, AST, 
BUN, CRE, NO and TNF-α, and improved LPS-induced tissue damage. Furthermore, 
the treatment of corylin decreased the mortality from LPS-induced systemic 
inflammation. 
 
Bavachin and corylin are flavonoids that derived from Psoralea corylifolia L.. These 
experimental results suggested that corylin exerted stronger inhibitory effects on 
LPS-induced NO production by murine peritoneal macrophages than bavachin. The half 
maximal inhibitory concentration (IC50) of corylin was approximate 20 μM, and 
bavachin was over 20 μM. Similar to bavachin, corylin also reduced LPS-induced 
production of NO and PGE2, and inhibited LPS-induced expression of iNOS and 
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COX-2. It is suggested that bavachin reduced the PGE2 production through inhibitory 
effect on mPGES-1 (PGH2 converts to PGE2), and corylin repressed the PGE2 
production through inhibitory effect on COX-2 (AA converts to PGH2). In addition, 
corylin suppressed phosphorylation of JNK 1/2, p38 MAPK and ERK 1/2, but bavachin 
did not affect p38 MAPK. Furthermore, corylin inhibited the production and 
translocation of HMBG1. Thus, corylin was further confirmed the anti-inflammatory 
effects on LPS-stimulated systemic inflammation by LPS-treated mice (in vivo). 
 
These experimental results indicated that mice exhibited inflammatory cascades (NO 
and TNF-α), multiple organ damage (lung, liver and kidney), sepsis and septic shock by 
LPS administration. The treatment of corylin improved LPS-induced tissue damage, and 
suppressed LPS-increased levels of ALT, AST, BUN and CRE. Additionally, corylin 
reduced LPS-induced production of NO and TNF-α, and increased the survival rate of 
LPS-triggered sepsis. 
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Chapter 5. Conclusions and suggestions for future research 
The LPS-induced inflammation is broadly involved with development of many 
inflammatory diseases. Notably, TLR4-mediated signaling transduction pathway plays 
an essential role in LPS-induced inflammation. TLR4-mediated signaling such as 
MAPKs and NF-κB contribute to produce pro-inflammatory mediators and cytokines by 
LPS-stimulated macrophages. Particularly, the acute inflammatory cascades lead to 
systemic inflammatory response syndrome, sepsis, multiple organ failure, and even 
death. Unfortunately, there are no specific therapeutic agents or supplementation on 
treatment of exercise-induced systemic inflammation currently. Therefore, the 
anti-inflammatory effects of polyphenols which are isolated from Camellia sinensis (L.) 
O. Kuntze and Psoralea corylifolia L. on LPS-induced inflammation were investigated 
in this thesis. 
 
These experimental results in Chapter 2 demonstrated EGCG exerted the strongest 
inhibitory effects on LPS-induced TNF-α and IL-6 production by RAW264 cells among 
polyphenols in green tea (Camellia sinensis). Additionally, pyrogallol-type structure 
might contributes to inhibit LPS-induced TNF-α and IL-6 production crucially, and 
flavan-3-ol structure regulates p38 MAPK. The green tea extracts (contain 41% EGCG) 
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exhibits anti-fatigue effect on swimming time [82], and enhance muscle strength 
recovery after downhill running [83]. Especially, green tea extract administration 
represses muscle inflammation induced by downhill running [83]. Thus, it suggests that 
EGCG is a potentially anti-inflammatory supplementation for treatment of 
exercise-induced inflammation. 
 
The experimental results in Chapters 3 and 4 suggested that bavachin and corylin, the 
polyphenols which are derived from Psoralea corylifolia L., repressed production of 
pro-inflammatory mediators and cytokines by LPS-activated macrophages. In addition, 
bavachin and corylin inhibited LPS-triggered MAPK and NF-κB activity. Moreover, 
bavachin repressed NLRP3 inflammasome-derived IL-1β production and caspase-1 
activation. Notably, corylin exhibited anti-inflammatory effect on LPS-induced systemic 
inflammation in mice (in vivo). Taken together, bavachin and corylin are potentially 
anti-inflammatory natural product candidates in the treatment of LPS-induced systemic 
inflammation (sepsis and exercise-induced endotoxemia). 
 
In this thesis, the anti-inflammatory effects of polyphenols which are derived from 
plants were confirmed using cell culture system, and anti-inflammatory natural product 
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candidates were selected. The candidates were confirmed by the anti-inflammatory 
effects in animal study. These experimental protocols and results provide the 
investigation of new anti-inflammatory natural products for future research. To examine 
the effects of oral corylin administration in animal study and to investigate the 
anti-inflammatory effects of corylin in human study are the suggestions for future 
corylin research. 
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